Qura, a Milan-based health platform, is reshaping the landscape of healthcare with a €1.5 million pre-seed investment round. The funding aims to provide a foundation for expanding their AI-driven health services at a time when many people suffer from persistent yet non-acute medical symptoms. By offering an integrated care solution, Qura is addressing a gap in the existing healthcare framework. Often, people with non-critical health concerns find themselves without the necessary support or guidance, and Qura intends to fill this void.
Historically, the healthcare industry has placed a heavy emphasis on acute care, which often overlooks the nuanced needs of those with chronic, subclinical symptoms. While the European health check-up market is on the rise, projected to hit €18.6 billion by 2030, primary healthcare systems have struggled to adapt to the growing demand for preventive services. Against this backdrop, Qura’s approach offers a timely and needed alternative, drawing on technological advancements to improve patient outcomes.
How Does Qura’s Model Work?
Qura delivers a personalized healthcare experience through comprehensive blood tests conducted at partner labs, followed by AI-assisted analysis. Patients then engage in a 45-minute consultation with a physician who crafts a tailored health plan. This plan includes immediate actions and sets the stage for long-term monitoring, aiming to empower patients with actionable insights.
What Sets Qura Apart in Healthcare?
The company’s hybrid care model places physicians at its core while leveraging AI for enhanced personalisation and efficiency. This dual approach aims to build stronger doctor-patient trust and improve patient adherence to care plans. Importantly, Qura is committed to maintaining regulatory alignment and ensuring data privacy, creating an EU-native platform that adheres to GDPR standards and integrates seamlessly with local lab networks.
The recent funding will be directed toward expanding Qura’s medical, engineering, and operations teams, as well as investing in digital marketing efforts to support community-led growth. Moreover, the company plans to enhance its AI health intelligence capabilities and is preparing to enter additional European markets. The comprehensive approach aims to tackle the chronic under-servicing of non-emergency medical needs.
Virginia Gambardella, CEO and founder of Qura, states that there is a critical oversight when it comes to healthcare priorities:
Millions of people know something is off, but the current system doesn’t give them the tools or the guidance to act.
By amalgamating AI with professional healthcare, Qura seeks to change this narrative.
Qura changes that – we combine the precision of AI with the trust of a real doctor to help people stay well, not just get better.
The emergence of companies like Qura signifies a shift towards personalized healthcare that takes into account both immediate and long-term needs of patients. As they aim to bridge the gap in healthcare services, Qura faces the challenge of proving their model not just profitable but also effective in improving patient care. By successfully leveraging AI and maintaining high regulatory standards, they could set a precedent for future healthcare solutions.
